KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $388,000 | -67.2% | 83,386 | -50.0% | 0.01% | -43.5% |
| Q3 2017 | $1,184,000 | +245.2% | 166,772 | +385.1% | 0.02% | +9.5% |
| Q2 2015 | $343,000 | -68.1% | 34,380 | -59.3% | 0.02% | -74.7% |
| Q1 2015 | $1,074,000 | -62.0% | 84,380 | -57.8% | 0.08% | -65.0% |
| Q4 2014 | $2,830,000 | +2.9% | 200,000 | 0.0% | 0.24% | -19.7% |
| Q3 2014 | $2,750,000 | -41.3% | 200,000 | -27.3% | 0.30% | -40.0% |
| Q1 2014 | $4,686,000 | +16.1% | 275,000 | -31.2% | 0.49% | +196.4% |
| Q3 2013 | $4,036,000 | +979.1% | 400,000 | +700.0% | 0.17% | +336.8% |
| Q2 2013 | $374,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |